10x Genomics (TXG) Income Statement: Revenue & Earnings

10x Genomics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

10x Genomics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Revenue & Gross Profit
Revenue	610.79	618.73	516.41	490.49	298.85	245.89
Cost of Revenue	196.00	209.41	120.39	74.09	58.47	61.03
Gross Profit	414.78	409.31	396.02	416.40	240.38	184.86
Operating Expenses
Research & Development	264.00	270.33	265.67	211.75	123.38	83.10
Selling, General & Administrative	343.24	343.33	298.30	257.56	202.33	130.83
Operating Expenses	607.24	613.66	563.97	469.31	325.70	215.43
Operating Income	-192.46	-204.35	-167.94	-52.91	-85.32	-30.57
Other Income/Expense
Interest Income	18.45	16.91	6.65	0.21	1.53	0.00
Interest Expense	0.00	0.03	-0.48	-0.87	-1.68	0.00
Other Income/Expense	0.52	-61.29	-0.20	0.10	0.04	0.19
Income
Income Before Tax	-177.70	-248.76	-161.97	-53.72	-534.48	-31.03
Income Tax Expense	4.93	6.34	4.03	4.51	8.26	0.22
Net Income	-182.63	-255.10	-166.00	-58.22	-542.73	-31.25
Net Income - Continuous Operations	-182.63	-255.10	-166.00	-58.22	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	-156.58	-205.11	-128.49	-31.80	-71.31	-20.79
EBIT	-192.46	-248.73	-161.50	-52.91	-85.32	-27.95
Depreciation & Amortization	35.88	43.62	22.80	21.12	14.01	61.03
Earnings Per Share
Basic EPS	-2.00	-2.00	-1.00	-1.00	-5.00	-1.00
Diluted EPS	-2.00	-2.00	-1.00	-1.00	-5.00	-1.00
Basic Shares Outstanding	120.45	117.17	113.86	110.35	101.15	39.09
Diluted Shares Outstanding	120.45	117.17	113.86	110.35	101.15	39.09